Exact Mass: 476.2635
Exact Mass Matches: 476.2635
Found 290 metabolites which its exact mass value is equals to given mass value 476.2635
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Betamethasone 17 Valerate
Calofloride
Mulberrofuran Z
Sophoraisoflavanone C
2-[2,3-Dihydro-2-(1-hydroxy-1-methylethyl)-7-(3-methyl-2-butenyl)-5-benzofuranyl]-2,3-dihydro-7-hydroxy-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
Betamethasone 17-valerate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids CONFIDENCE standard compound; INTERNAL_ID 2833 D000893 - Anti-Inflammatory Agents
-4-Chloro-3-hydroxy-23-oxoergost-24(28)-en-21-oic acid
7-hydroxy-2-[3-hydroxy-2,2-dimethyl-8-(3-methylbut-2-enyl)-3,4-dihydrochromen-6-yl]-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
3,4-dehydro-4-dehydroxypodachaenin|3-costoyloxydehydroleucodin
lespeflorin B3
A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3, 7 and 4 and prenyl groups at positions 6, 8 and 3. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
Betamethasone valerate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9654; ORIGINAL_PRECURSOR_SCAN_NO 9651 CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9695; ORIGINAL_PRECURSOR_SCAN_NO 9693 CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9706; ORIGINAL_PRECURSOR_SCAN_NO 9701 CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9748; ORIGINAL_PRECURSOR_SCAN_NO 9744 CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9758; ORIGINAL_PRECURSOR_SCAN_NO 9757 CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9768; ORIGINAL_PRECURSOR_SCAN_NO 9765
Asp Lys Lys Ser
Asp Lys Ser Lys
Asp Ser Lys Lys
Phe Ile Pro Thr
Phe Ile Thr Pro
Phe Leu Pro Thr
Phe Leu Thr Pro
Phe Pro Ile Thr
Phe Pro Leu Thr
Phe Pro Thr Ile
Phe Pro Thr Leu
Phe Thr Ile Pro
Phe Thr Leu Pro
Phe Thr Pro Ile
Phe Thr Pro Leu
Ile Phe Pro Thr
Ile Phe Thr Pro
Ile Ile Met Thr
Ile Ile Thr Met
Ile Leu Met Thr
Ile Leu Thr Met
Ile Met Ile Thr
Ile Met Leu Thr
Ile Met Thr Ile
Ile Met Thr Leu
Ile Pro Phe Thr
Ile Pro Thr Phe
Ile Thr Phe Pro
Ile Thr Ile Met
Ile Thr Leu Met
Ile Thr Met Ile
Ile Thr Met Leu
Ile Thr Pro Phe
Lys Asp Lys Ser
Lys Asp Ser Lys
Lys Lys Asp Ser
Lys Lys Ser Asp
Lys Gln Thr Thr
Lys Arg Ser Ser
Lys Ser Asp Lys
Lys Ser Lys Asp
Lys Ser Arg Ser
Lys Ser Ser Arg
Lys Thr Gln Thr
Lys Thr Thr Gln
Leu Phe Pro Thr
Leu Phe Thr Pro
Leu Ile Met Thr
Leu Ile Thr Met
Leu Leu Met Thr
Leu Leu Thr Met
Leu Met Ile Thr
Leu Met Leu Thr
Leu Met Thr Ile
Leu Met Thr Leu
Leu Pro Phe Thr
Leu Pro Thr Phe
Leu Thr Phe Pro
Leu Thr Ile Met
Leu Thr Leu Met
Leu Thr Met Ile
Leu Thr Met Leu
Leu Thr Pro Phe
Met Ile Ile Thr
Met Ile Leu Thr
Met Ile Thr Ile
Met Ile Thr Leu
Met Leu Ile Thr
Met Leu Leu Thr
Met Leu Thr Ile
Met Leu Thr Leu
Met Thr Ile Ile
Met Thr Ile Leu
Met Thr Leu Ile
Met Thr Leu Leu
Pro Phe Ile Thr
Pro Phe Leu Thr
Pro Phe Thr Ile
Pro Phe Thr Leu
Pro Ile Phe Thr
Pro Ile Thr Phe
Pro Leu Phe Thr
Pro Leu Thr Phe
Pro Thr Phe Ile
Pro Thr Phe Leu
Pro Thr Ile Phe
Pro Thr Leu Phe
Pro Val Val Tyr
Pro Val Tyr Val
Pro Tyr Val Val
Gln Lys Thr Thr
Gln Thr Lys Thr
Gln Thr Thr Lys
Arg Lys Ser Ser
Arg Ser Lys Ser
Arg Ser Ser Lys
Ser Asp Lys Lys
Ser Lys Asp Lys
Ser Lys Lys Asp
Ser Lys Arg Ser
Ser Lys Ser Arg
Ser Arg Lys Ser
Ser Arg Ser Lys
Ser Ser Lys Arg
Ser Ser Arg Lys
Thr Phe Ile Pro
Thr Phe Leu Pro
Thr Phe Pro Ile
Thr Phe Pro Leu
Thr Ile Phe Pro
Thr Ile Ile Met
Thr Ile Leu Met
Thr Ile Met Ile
Thr Ile Met Leu
Thr Ile Pro Phe
Thr Lys Gln Thr
Thr Lys Thr Gln
Thr Leu Phe Pro
Thr Leu Ile Met
Thr Leu Leu Met
Thr Leu Met Ile
Thr Leu Met Leu
Thr Leu Pro Phe
Thr Met Ile Ile
Thr Met Ile Leu
Thr Met Leu Ile
Thr Met Leu Leu
Thr Pro Phe Ile
Thr Pro Phe Leu
Thr Pro Ile Phe
Thr Pro Leu Phe
Thr Gln Lys Thr
Thr Gln Thr Lys
Thr Thr Lys Gln
Thr Thr Gln Lys
Val Pro Val Tyr
Val Pro Tyr Val
Val Val Pro Tyr
Val Val Tyr Pro
Val Tyr Pro Val
Val Tyr Val Pro
Tyr Pro Val Val
Tyr Val Pro Val
Tyr Val Val Pro
(2S)-2-[bis(carboxymethyl)amino]-6-(12-sulfanyldodecanoylamino)hexanoic acid
4-Morpholinepropanoic acid,oxybis(2,1-ethanediyloxy-2,1-ethanediyl)ester
6-[(4-{2-[4-(2-Methyl-2-propanyl)phenyl]-1H-benzimidazol-4-yl}-1- piperazinyl)methyl]quinoxaline
schizolaenone A
A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7 and 4, a geranyl group at position 3 and a prenyl group at position 6. Isolated from Schizolaena hystrix, it exhibits cytotoxicity against ovarian cancer cell line.